Medicover AB (publ) (MCOV-B) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.170x

Based on the latest financial reports, Medicover AB (publ) (MCOV-B) has a cash flow conversion efficiency ratio of 0.170x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr980.72 Million ≈ $105.54 Million USD) by net assets (Skr5.76 Billion ≈ $619.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medicover AB (publ) - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Medicover AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MCOV-B liabilities breakdown for a breakdown of total debt and financial obligations.

Medicover AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicover AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Dis-Chem Pharmacies
JSE:DCP
0.341x
Zhejiang CONBA Pharmaceutical Co Ltd
SHG:600572
0.019x
Sionna Therapeutics, Inc. Common Stock
NASDAQ:SION
-0.054x
Chengdu Easton Biopharmaceuticals Co Ltd
SHG:688513
0.021x
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
0.009x
TX Group AG
SW:TXGN
0.039x
Syndax Pharmaceuticals Inc
NASDAQ:SNDX
-0.611x
Guangdong Yizumi Precision Machinery Co Ltd
SHE:300415
-0.009x

Annual Cash Flow Conversion Efficiency for Medicover AB (publ) (2005–2024)

The table below shows the annual cash flow conversion efficiency of Medicover AB (publ) from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see MCOV-B stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr489.30 Million
≈ $52.66 Million
Skr261.90 Million
≈ $28.18 Million
0.535x +37.94%
2023-12-31 Skr528.30 Million
≈ $56.85 Million
Skr205.00 Million
≈ $22.06 Million
0.388x +16.46%
2022-12-31 Skr510.80 Million
≈ $54.97 Million
Skr170.20 Million
≈ $18.32 Million
0.333x -13.57%
2021-12-31 Skr562.10 Million
≈ $60.49 Million
Skr216.70 Million
≈ $23.32 Million
0.386x +19.49%
2020-12-31 Skr483.50 Million
≈ $52.03 Million
Skr156.00 Million
≈ $16.79 Million
0.323x +32.94%
2019-12-31 Skr359.70 Million
≈ $38.71 Million
Skr87.30 Million
≈ $9.39 Million
0.243x +77.05%
2018-12-31 Skr323.90 Million
≈ $34.86 Million
Skr44.40 Million
≈ $4.78 Million
0.137x -17.15%
2017-12-31 Skr304.00 Million
≈ $32.72 Million
Skr50.30 Million
≈ $5.41 Million
0.165x -36.88%
2016-12-31 Skr98.80 Million
≈ $10.63 Million
Skr25.90 Million
≈ $2.79 Million
0.262x -14.87%
2015-12-31 Skr93.20 Million
≈ $10.03 Million
Skr28.70 Million
≈ $3.09 Million
0.308x +28.43%
2014-12-31 Skr90.50 Million
≈ $9.74 Million
Skr21.70 Million
≈ $2.34 Million
0.240x +14.91%
2005-12-31 Skr23.55 Million
≈ $2.53 Million
Skr4.91 Million
≈ $528.82K
0.209x --

About Medicover AB (publ)

ST:MCOV-B Sweden Medical Care Facilities
Market Cap
$1.66 Billion
Skr15.44 Billion SEK
Market Cap Rank
#6949 Global
#96 in Sweden
Share Price
Skr207.50
Change (1 day)
-1.19%
52-Week Range
Skr182.20 - Skr285.50
All Time High
Skr369.18
About

Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company's Diagnostic Servi… Read more